본문으로 건너뛰기
← 뒤로

Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment.

1/5 보강
Clinical cancer research : an official journal of the American Association for Cancer Research 📖 저널 OA 56.2% 2022: 3/4 OA 2023: 6/8 OA 2024: 8/14 OA 2025: 57/92 OA 2026: 87/165 OA 2022~2026 2024 Vol.30(11) p. 2297-2299
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: pancreatic cancer
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
See related article by Carpenter et al., p. 2497.

Faraoni EY, McAllister F

📝 환자 설명용 한 줄

KRT17-high intermediate cell population with elevated CXCL8 expression informed elevated myeloid infiltration status in tumors and associated with protumorigenic signatures in peripheral granulocytes

이 논문을 인용하기

↓ .bib ↓ .ris
APA Faraoni EY, McAllister F (2024). Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment.. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(11), 2297-2299. https://doi.org/10.1158/1078-0432.CCR-23-3295
MLA Faraoni EY, et al.. "Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment.." Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 30, no. 11, 2024, pp. 2297-2299.
PMID 38530840 ↗

Abstract

KRT17-high intermediate cell population with elevated CXCL8 expression informed elevated myeloid infiltration status in tumors and associated with protumorigenic signatures in peripheral granulocytes from patients with pancreatic cancer. Furthermore, CXCL8 plasma levels were found to resemble KRT17+/CXCL8+ abundance in tumors, in which higher levels predicted worse patient outcomes. See related article by Carpenter et al., p. 2497.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반